Close Menu

MDxHealth

NEW YORK (GenomeWeb) – MDxHealth today announced the signing of agreements that increase the number of covered lives with access to its ConfirmMDx for Prostate Cancer test to more than 152 million in the US.

NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA has issued draft local coverage determinations stipulating reimbursement criteria for three multi-marker molecular diagnostics: Assurex Health's pharmacogenetic test for refractory depression, MDxHealth's ConfirmMDx epigenetic prostate cance

NEW YORK (GenomeWeb) – MDxHealth today announced a deal with Miraca Life Sciences to promote MDxHealth's ConfirmMDx Prostate Cancer test.

Genomic Health Publishes Development, Validation Studies on Oncotype DX Prostate Cancer Dx
Genomic Health has published in European Urology data from three studies involving its 17-gene Oncotype DX prostate cancer test.

NEW YORK (GenomeWeb) – MDxHealth said today that American Pathology Partners will promote and co-market the firm's ConfirmMDx for Prostate Cancer test in the US.

NEW YORK (GenomeWeb) – MDxHealth today reported a 36 percent year-over-year increase in its first quarter revenues as sales of its prostate cancer test grew nearly five-fold.

NEW YORK (GenomeWeb) – MDxHealth today announced an agreement with preferred provider organization Galaxy Health Network to provide access to MDxHealth's ConfirmMDx for Prostate Cancer test.

NEW YORK (GenomeWeb News) – MDxHealth today said that it has signed a co-marketing agreement with Long Island Pathology to promote MDxHealth's ConfirmMDx for Prostate Cancer test.

NEW YORK (GenomeWeb News) – MDxHealth today reported a 24 percent drop in revenues for its fourth quarter.

NEW YORK (GenomeWeb News) – MDxHealth today said that it has signed an agreement with preferred provider organization Prime Health Services to offer its ConfirmMDx for Prostate Cancer test to Prime Health's members.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.